FDA Fast-Tracks First Treatment for Alexander Disease

The FDA has accepted a groundbreaking treatment for Alexander disease for priority review, offering hope to families battling a rare neurological condition that has no approved therapies.

If approved by September, zilganersen would become the first medicine ever available for this devastating illness.